期刊文献+

RT-PCR检测肾移植术后血浆、尿及白细胞中巨细胞病毒感染的临床意义 被引量:1

Clinical significance of RT-PCR in determination of cytomegalovirus in urine,plasma and leukocyte in renal transplant recipients
下载PDF
导出
摘要 目的比较RTPCR连续动态监测肾移植患者血、尿及白细胞中巨细胞病毒(CMV)载量的临床意义。方法接受同种异体肾移植的患者共56例,应用RTPCR动态监测血、尿及白细胞中CMVDNA载量,比较三类标本检测的阳性率、病毒载量的变化以及与CMV肺炎的相关性。结果血浆、尿液和白细胞中的检出率分别为85.7%、87.5%和92.5%。采用术后第5~15周内连续三次病毒载量大于104拷贝/ml作为预测CMV肺炎的指标,三类标本均有令人满意的灵敏度、特异度、阳性和阴性预测值。尿液检测的灵敏度最高,白细胞的Kappa一致性最优,预警时间以尿标本为最佳。结论连续动态监测病毒载量是临床上预警CMV肺炎的有效手段,血浆、尿液和白细胞这三类标本均有独立价值。 Objective To compare the clinical significance of dynamic surveillance of CMV-DNA in urine, plasma and leukocyte in renal transplant recipients by RT-PCR. Methods CMV-DNA in urine, plasma and leukocyte was dynamically determined in 56 renal transplant patients by RT- PCR,and the positive rate, variation of viral load and the relativity with CMV interstitial pneumonia (CMV-IP) were compared. Results Positive rates of CMV-DNA in urine,plasma and leukocyte were 87. 5%, 85.7% and 92.5%, respectively. The sensitivity, specificity, positive and negative predictive level of the three specimens were all satisfactory when viral load over 10^4 copy/ml for continuous three weeks was used as a predictive index. Urine sample had the highest sensitivity,and leukocyte sample had the most excellent kappa coherence. The prealarm time of urine sample was the best. Condusion Each of the three specimens owns independent value in predicting CMV-IP after renal transplantation.
出处 《江苏医药》 CAS CSCD 北大核心 2006年第8期713-715,共3页 Jiangsu Medical Journal
关键词 肾移植 巨细胞病毒 肺炎 病毒载量 Renal transplantation Cytomegalovirus Pneumonia Viral load
  • 相关文献

参考文献7

  • 1Proschs S,Kimel V,Dawydowa I,et al.Monitoring of patients for cytomegalovirus after organ transplantation by centrifugation culture and PCR.J Med Virol,1992,38:246-251.
  • 2严晓敏,唐勤,陈明,孙则禹.荧光定量PCR和外周血白细胞pp65抗原血症实验对肾移植术后巨细胞病毒感染的检测[J].江苏医药,2003,29(12):890-892. 被引量:4
  • 3Hadaya K,Wunderli W,Deffernez C,et al.Monitoring of cytomegalovirus infection in solid-organ transplant recipients by an ultrasensitive plasma PCR assay.J Clin Microbiol,2003,41:3757-3764.
  • 4Eriksson B,Wirgart K,Claesson G,et al.A prospective study of rapid methods of detecting cytomegalovirus in the blood of renal transplant recipients in relation to patient and graft survival.Clin Transplant,1996,10:494-502.
  • 5Tanaka K,Noda S.Role of nitric oxide in murine cytomegalovirus(MCMV) infection.Histol Histopathol,2001,16:937-944.
  • 6Honda J,Yonemitsu J,Kitajima H,et al.Clinical utility of capillary polymerase chain reaction for diagnosis of cytomegalovirus pneumonia.Scand J Infect Dis,2001,33:702-705.
  • 7黎磊石,刘志红.原发性高血压的肾损害[J].肾脏病与透析肾移植杂志,2004,13(4):336-337. 被引量:50

二级参考文献6

  • 1[1]Morris DJ.Cytomegalovirus pneumonia-aconsequence of immunosuppression and pre-existing lung damage rather than immunopathology?Respir Med,1993,87:345-349.
  • 2[3]Ram-Peddi V,Hariharan S,Schroeder TJ,et al.Impact of ganciclovir prophylaxis in cytomegalovirus infection in recipi-ents of cadavericrenal allografts.Nephron,1997,76:49-55.
  • 3[4]Singh N,Paterson DL,Gayowski T,et al.Cytomegalovirus antigenemia directed preemptive prophylaxis with oral versus I.V. ganciclovir for the prevention of cytomegalovirus disease in liver transplant recipients:a randomized,controlled trial.Transplantation,2000,70:717-722.
  • 4[5]Solano C,Munoz I,Gutierrez A,et al.Qualitative plasma PCR assay(AMPLICOR CMV test)versus pp65 antigenemia assay for monitoring cytomegalovirus viremia and guiding preemptive ganciclovir therapy in allogeneic stem cell transplantation.J Clin Microbiol,2001,39:3938-3941.
  • 5[6]Naoko T,Hiroshi K,Keiji I,et al.Quantitative analysis of cytomegalovirus load using a real time PCR assay.J Med Viro,2000,60:455-462.
  • 6洪良庆,郑克立,朱兰英,吴培根,王晓波.白细胞中巨细胞病毒抗原检测及在肾移植的临床应用[J].中华医学检验杂志,1998,21(1):33-35. 被引量:35

共引文献52

同被引文献9

引证文献1

二级引证文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部